Home›Companies›Biotech & Pharma›Rebase Biotech

Rebase Biotech, Inc

Updated Oct 27, 2026·Latest SEC filing Mar 21, 2023·Suggest an edit

About Rebase Biotech

Rebase Biotech is a private company based in Duluth, Minnesota, incorporated in 2023 in Delaware. It has reported $400,000 raised in one offering on Form D since March 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 10, 2023Mar 21, 2023$400,000of $1.0M target5$80,000SAFE(simple agreement for future equity)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Rebase Biotech's Form D filed Mar 21, 2023.

SM

Sources

  1. SECRebase Biotech, Inc filing history